TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.700
-0.160 (-4.15%)
Oct 30, 2026, 4:00 PM EDT - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $227.83 million as of October 30, 2026. It is the 19,765th most valuable company in the world and the 3,461st biggest in the United States. Its market cap has decreased by 3.62% in one year.
Market Cap
227.83M
Enterprise Value
215.96M
1-Year Change
-3.62%
Global Rank
Country Rank
#3,461 United States
Category
ChartMarket Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $227.83M, a decrease of -30.70%. That is a compound annual growth rate of -6.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 227.83M | -34.67% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CapsoVision | 341.82M |
| Quantum-Si incorporated | 319.57M |
| Treace Medical Concepts | 288.10M |
| InfuSystem Holdings | 280.23M |
| Profound Medical | 240.91M |
| Standard BioTools | 239.47M |
| Electromed | 224.08M |
| RxSight | 202.56M |